Fatty Liver Disease
Drug | Drug Name | Drug Description |
---|---|---|
DB09298 | Silibinin | A flavonolignan with hepatoprotective effects used to treat toxic liver damage and as an adjunct in the management of chronic conditions such as cirrhosis and hepatitis. |
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB00736 | Esomeprazole | 1 / 2 | Not Yet Recruiting | 1 |
DB04924 | Itopride | 2 | Not Yet Recruiting | 1 |
DB08930 | Dolutegravir | 4 | Active Not Recruiting | 1 |
DB00879 | Emtricitabine | 4 | Active Not Recruiting | 1 |
DB08864 | Rilpivirine | 4 | Active Not Recruiting | 1 |
DB09299 | Tenofovir alafenamide | 4 | Active Not Recruiting | 1 |
DB00300 | Tenofovir disoproxil | 4 | Active Not Recruiting | 1 |
DB08907 | Canagliflozin | Not Available | Completed | 1 |
DB09038 | Empagliflozin | Not Available | Not Yet Recruiting | 1 |